Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple ...

Rooftop solar solutions startup ZunRoof has raised INR 20 Cr in a funding round led by the Godrej family office, ANBG ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Oracle ...

A Delaunay triangulation of a vertex set is a triangulation of the vertex set with the property that no vertex in the vertex set falls in the interior of the circumcircle (circle that passes through ...

Walk roughly in a circle surround the scene/object ... The second one from the left shows the vertex points of the model. You can also switch these mode from the Layer Dialog. Press Shift to subtract ...

It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have lost about 8.6% in that time frame, underperforming the S&P 500. Will the recent negative ...

Jefferies has upgraded Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), citing the company’s robust cystic fibrosis base business and the additional upside from the new LNP/ mRNA therapy (around $1 ...

Vertex Pharmaceuticals Inc.’s nonaddictive drug for lower back pain didn’t do better than a placebo in a midstage trial, causing the company’s shares to fall. Vertex will continue testing ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.